A detailed history of Wedbush Securities Inc transactions in Dexcom Inc stock. As of the latest transaction made, Wedbush Securities Inc holds 13,014 shares of DXCM stock, worth $1.04 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
13,014
Previous 13,227 1.61%
Holding current value
$1.04 Million
Previous $1.5 Million 41.87%
% of portfolio
0.03%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$64.0 - $116.06 $13,632 - $24,720
-213 Reduced 1.61%
13,014 $872,000
Q2 2024

Aug 06, 2024

SELL
$110.31 - $140.45 $25,371 - $32,303
-230 Reduced 1.71%
13,227 $1.5 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $17,932 - $21,995
157 Added 1.18%
13,457 $1.87 Million
Q4 2023

Feb 12, 2024

SELL
$75.49 - $124.16 $25,515 - $41,966
-338 Reduced 2.48%
13,300 $1.65 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $27,367 - $43,861
-318 Reduced 2.28%
13,638 $1.27 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $72,093 - $83,958
-641 Reduced 4.39%
13,956 $1.79 Million
Q1 2023

May 09, 2023

SELL
$104.0 - $122.92 $33,384 - $39,457
-321 Reduced 2.15%
14,597 $1.7 Million
Q4 2022

Jan 31, 2023

BUY
$84.98 - $122.67 $5,608 - $8,096
66 Added 0.44%
14,918 $1.69 Million
Q3 2022

Oct 18, 2022

SELL
$76.35 - $94.18 $15,651 - $19,306
-205 Reduced 1.36%
14,852 $1.2 Million
Q2 2022

Jul 21, 2022

BUY
$67.99 - $132.89 $771,278 - $1.51 Million
11,344 Added 305.52%
15,057 $1.12 Million
Q1 2022

Apr 19, 2022

BUY
$94.08 - $130.2 $6,115 - $8,463
65 Added 1.78%
3,713 $474,000
Q4 2021

Jan 13, 2022

SELL
$129.87 - $162.82 $2,207 - $2,767
-17 Reduced 0.46%
3,648 $489,000
Q3 2021

Oct 08, 2021

BUY
$106.71 - $143.18 $5,442 - $7,302
51 Added 1.41%
3,665 $501,000
Q2 2021

Jul 27, 2021

BUY
$80.99 - $107.93 $16,521 - $22,017
204 Added 5.98%
3,614 $385,000
Q1 2021

Apr 26, 2021

BUY
$84.79 - $104.74 $678 - $837
8 Added 0.24%
3,410 $306,000
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $10,920 - $14,630
-140 Reduced 3.95%
3,402 $1.26 Million
Q3 2020

Oct 20, 2020

SELL
$95.51 - $112.95 $15,472 - $18,297
-162 Reduced 4.37%
3,542 $1.46 Million
Q2 2020

Jul 16, 2020

BUY
$62.68 - $105.34 $20,496 - $34,446
327 Added 9.68%
3,704 $1.5 Million
Q1 2020

Apr 17, 2020

BUY
$47.79 - $75.63 $5,400 - $8,546
113 Added 3.46%
3,377 $909,000
Q4 2019

Jan 16, 2020

SELL
$36.62 - $57.29 $512 - $802
-14 Reduced 0.43%
3,264 $714,000
Q3 2019

Oct 17, 2019

BUY
$35.53 - $43.8 $6,040 - $7,445
170 Added 5.47%
3,278 $489,000
Q2 2019

Aug 01, 2019

BUY
$27.84 - $38.92 $3,619 - $5,059
130 Added 4.37%
3,108 $466,000
Q1 2019

Apr 17, 2019

SELL
$28.07 - $38.18 $196 - $267
-7 Reduced 0.23%
2,978 $355,000
Q4 2018

Jan 31, 2019

SELL
$26.99 - $37.37 $14,412 - $19,955
-534 Reduced 15.17%
2,985 $358,000
Q3 2018

Nov 13, 2018

SELL
$23.35 - $36.72 $467 - $734
-20 Reduced 0.57%
3,519 $503,000
Q2 2018

Aug 03, 2018

BUY
$17.54 - $25.22 $1,473 - $2,118
84 Added 2.43%
3,539 $336,000
Q1 2018

May 01, 2018

SELL
$13.06 - $18.54 $27,870 - $39,564
-2,134 Reduced 38.18%
3,455 $256,000
Q4 2017

Feb 09, 2018

BUY
$11.12 - $15.38 $12,109 - $16,748
1,089 Added 24.2%
5,589 $321,000
Q3 2017

Oct 31, 2017

BUY
$11.36 - $18.98 $51,120 - $85,410
4,500
4,500 $220,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.